Showing results (231-240 of 645) with videos related to
Sort By:
Pageof 65
Blood|January 14, 2014
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapyJennifer A Woyach, Kelly Smucker, Lisa L Smith, et al.Blood Advances|September 13, 2021
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapyDavid A Bond, Jeffrey M Switchenko, Diego Villa, et al.Cancers|March 11, 2023
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's LymphomaWalter Hanel, Polina Shindiapina, David A Bond, et al.Blood Advances|January 4, 2018
Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinibTracy E Wiczer, Lauren B Levine, Jessica Brumbaugh, et al.Annals of Palliative Medicine|April 9, 2021
Discussing diabetes, palliative and end of life care: choosing the 'right' languageTrisha Dunning, Peter Martin, Sharyn Milnes, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 4, 2019
Defining a new model of interdisciplinary cancer cachexia care in regional Victoria, AustraliaVanessa C Vaughan, Helen Farrell, Paul A Lewandowski, et al.Surgical Endoscopy|January 27, 2023
Robot-assisted TAMIS: a systematic review of feasibility and outcomesP Cornelius H Jakobsen, Peter-Martin Krarup, Kristian K Jensen, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 14, 2016
The Relationship of Fertility, Lifestyle, and Longevity Among WomenPeggy A Lockhart, Peter Martin, Mary Ann Johnson, et al.Journal of the American Academy of Child and Adolescent Psychiatry|April 5, 2019
Prognostic Implications for Adolescents With Depression Who Drop Out of Psychological Treatment During a Randomized Controlled TrialSally O'Keeffe, Peter Martin, Ian M Goodyer, et al.Leukemia & Lymphoma|February 25, 2021
Evaluation of the prognostic utility of bone marrow biopsy in diffuse large B-Cell lymphoma in the SEER-Medicare datasetDanny Luan, Yiyuan Wu, Jordan Goldstein, et al.Pageof 65